$BMRAAug 27, 2026, 11:49 AM ETAI processed
Biomerica private placement: 1.3937M shares at $1.60 to raise ~$2.23M
AI Summary
Biomerica agreed to sell 1,393,705 unregistered shares of common stock at $1.60 per share in a private placement expected to raise approximately $2.23 million; the financing includes no warrants. Participation included B. Riley Principal Capital, certain B. Riley executives, the CEO and all board members; issuance is tied to closing and the company says pro forma shares outstanding would be ~4,588,968 (new shares ≈30.4% of pro forma). Timing: The press release does not indicate dilution today. Earliest dilution: date unknown.
Positives
- No warrants or discounted securities were issued, reducing future warrant overhang
- Participation by CEO, full board and B. Riley affiliates shows alignment with management
- Company intends to use proceeds to strengthen balance sheet and fund operations
Negatives
- Financing represents substantial dilution — new shares ~30.4% of pro forma outstanding
- Shares are unregistered (private placement), implying resale restrictions for investors
- Press release provides no firm closing date, so timing of dilution is uncertain
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: date unknown
Dilution status
delayed
Dilution timing
Dilution status: Delayed